VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, December 31, 2025
Stock Comparison
Amgen Inc. vs Medtronic plc
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Amgen Inc.
AMGN · Nasdaq Stock Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Medtronic plc
MDT · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Medtronic plc's moat claims, evidence, and risks.
View MDT analysisComparison highlights
- Moat score gap: Amgen Inc. leads (70 / 100 vs 63 / 100 for Medtronic plc).
- Segment focus: Amgen Inc. has 3 segments (80.1% in Core Innovative Medicines); Medtronic plc has 4 segments (37.2% in Cardiovascular Portfolio).
- Primary market structure: Competitive vs Oligopoly. Pricing power: Moderate vs Moderate.
- Moat breadth: Amgen Inc. has 5 moat types across 3 domains; Medtronic plc has 9 across 3.
Primary market context
Amgen Inc.
Core Innovative Medicines
Branded biopharmaceutical therapies for common diseases (bone health, inflammation, oncology, cardiovascular and other specialty areas)
Global
Payers, providers, and pharmacies
Drug developer/manufacturer
80.1%
Medtronic plc
Cardiovascular Portfolio
Cardiovascular medical devices (cardiac rhythm management, electrophysiology/ablation, structural heart, coronary & peripheral vascular)
Global
Hospitals, cath labs, electrophysiologists, cardiologists, cardiac & vascular surgeons
Device OEM + procedure support + remote monitoring software/services
37.2%
Side-by-side metrics
Moat coverage
Shared moat types
Amgen Inc. strengths
Medtronic plc strengths
Segment mix
Amgen Inc. segments
Full profile >Core Innovative Medicines
Competitive
Rare Disease Portfolio (Horizon + others)
Quasi-Monopoly
Biosimilars
Oligopoly
Medtronic plc segments
Full profile >Cardiovascular Portfolio
Oligopoly
Neuroscience Portfolio
Oligopoly
Medical Surgical Portfolio
Competitive
Diabetes Operating Unit
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.